Headquarters: Sydney, NSW, Australia
Founded: 1987. Parts of the company have operated for many decades
CEO: Dr. Colin Stephen Goldschmidt
AUD as of April 1, 2022
Sonic Healthcare Limited is a medical company specializing in diagnostics services. It provides services in pathology/laboratory medicine and imaging/radiology. Having grown through international acquisitions, Sonic Healthcare now operates in Australia, New Zealand, United States, United Kingdom, Germany, Switzerland, Belgium, and Ireland
Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
Sonic Healthcare Limited is an Australian company that provides laboratory services, pathology, and radiology services. The Sydney-based company has its roots in the pathology practice of Douglass Laboratories, and since has become one of Australia's largest diagnostic companies. It has a presence in Australia, New Zealand, United States, United Kingdom, Germany, Switzerland, Belgium and Ireland. It is the largest medical laboratory provider in Australasia and Europe and the third largest in the US, it employs over 37,000 people. It was listed on the Australian Stock Exchange in 1987 as Sonic Technology Australia Ltd. The company changed its name to Sonic Healthcare Ltd in 1995. It is now part of the S&P/ASX 50, and is one of the largest medical companies listed on the ASX, CSL Limited, Cochlear and ResMed being the only other listed medical companies of comparable size. The company strategy is growth by acquisition of overseas companies. With many critiques arguing that such a strategy can lead to over diversification, yet has seemingly worked well to expand its business There is limited opportunity to expand further in the Australian marketplace and income in Australia is largely dependent on government health funding through Medicare. The firm has diversified its revenue base with moves offshore from Australia. Annual Revenues for Financial Year to June 30, 2019 exceeded A$6.2 billion. Dr Colin Goldschmidt is the CEO and Managing Director.
Source: Wikipedia, retrieved on April 15, 2021, 7:59 p.m.
Pathology/laboratory medicine and Imaging/radiology
Dr Colin Goldschmidt (CEO, Managing Director)
Revenue: A$6.2 billion (2019)